The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes
Open accessAbstract
Osteocytes secrete paracrine factors that regulate the balance between bone formation and destruction. Among these molecules, sclerostin (encoded by the gene SOST) inhibits osteoblastic bone formation and is an osteoporosis drug target. The molecular mechanisms underlying SOST expression remain largely unexplored. Here, we report that histone deacetylase 5 (HDAC5) negatively regulates sclerostin levels in osteocytes in vitro and in vivo. HDAC5 shRNA increases, whereas HDAC5 overexpression decreases SOST expression in the novel murine Ocy454 osteocytic cell line. HDAC5 knockout mice show increased levels of SOST mRNA, more sclerostin-positive osteocytes, decreased Wnt activity, low trabecular bone density, and reduced bone formation by osteoblasts. In osteocytes, HDAC5 binds and inhibits the function of MEF2C, a crucial transcription factor for SOST expression. Using chromatin immunoprecipitation, we have mapped endogenous MEF2C binding in the SOST gene to a distal intergenic enhancer 45 kB downstream from the transcription start site. HDAC5 deficiency increases SOST enhancer MEF2C chromatin association and H3K27 acetylation and decreases recruitment of corepressors NCoR and HDAC3. HDAC5 associates with and regulates the transcriptional activity of this enhancer, suggesting direct regulation of SOST gene expression by HDAC5 in osteocytes. Finally, increased sclerostin production achieved by HDAC5 shRNA is abrogated by simultaneous knockdown of MEF2C, indicating that MEF2C is a major target of HDAC5 in osteocytes. © 2014 American Society for Bone and Mineral Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, Sato et al.20,44 showed that FFSS induces the disruption of the FAK-integrin complex, thereby inhibiting histone deacetylase 4/5 (HDAC4/5), a negative regulator of SOST expression in osteocytes45 modulated by parathyroid hormone (PTH) treatment.46”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Haberland, M., Montgomery, R. L., & Olson, E. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,600
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semënov, M. V., Han, C., Baeg, G., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,152
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
Self-citationA Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,804
Self-citationEvidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778
ChIP-seq accurately predicts tissue-specific activity of enhancers
Visel, A., Blow, M. J., Li, Z., Zhang, T., Akiyama, J. A., Holt, A., Plajzer-Frick, I., Shoukry, M., Wright, C., Chen, F., et al. (2009) · Nature · doi:10.1038/nature07730 · Cited by 1,639
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
Robling, A. G., Niziolek, P. J., Baldridge, L. A., Condon, K. W., Allen, M. R., Alam, I., Mantila, S. M., Gluhak-Heinrich, J., Bellido, T. M., Harris, S. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705092200 · Cited by 1,350
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Estrada, K., Styrkársdóttir, U., Εvangelou, Ε., Hsu, Y., Duncan, E. L., Ntzani, E., Oei, L., Albagha, O., Amin, N., Kemp, J. P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2249 · Cited by 1,184
Charting histone modifications and the functional organization of mammalian genomes
Zhou, V. W., Goren, A., & Bernstein, B. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2905 · Cited by 1,147
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Li, X., Ominsky, M. S., Niu, Q., Sun, N., Daugherty, B., D’Agostin, D. M., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 941
Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754
Rivadeneira, F., Estrada, K., Zillikens, M. C., van Meurs, J. B. J., Pols, H. A. P., Uitterlinden, A. G., Amin, N., Aulchenko, Y. S., Albert Hofman, D., van Duijn, C. M., et al. (2009) · Nature Genetics · doi:10.1038/ng.446 · Cited by 711
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698
Lin, C., Jiang, X., Dai, Z., Guo, X., Weng, T., Wang, J., Li, Y., Feng, G., Gao, X., & He, L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090411 · Cited by 648
Bellido, T., Ali, A., Gubrij, I. B., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 640
SOST is a target gene for PTH in bone
Keller, H., & Kneissel, M. (2005) · Bone · doi:10.1016/j.bone.2005.03.018 · Cited by 618
Chang, S., McKinsey, T. A., Zhang, C. L., Richardson, J. A., Hill, J. A., & Olson, E. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8467-8476.2004 · Cited by 612
Histone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli
Renthal, W., Maze, I., Krishnan, V., Covington, H. E., Xiao, G., Kumar, A., Russo, S. J., Graham, A., Tsankova, N., Kippin, T. E., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.032 · Cited by 599
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfı́, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706487104 · Cited by 566
Vega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N., & McKinsey, T. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8374-8385.2004 · Cited by 512
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Wijenayaka, A. R., Kogawa, M., Lim, H. P., Bonewald, L. F., Findlay, D. M., & Atkins, G. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025900 · Cited by 503
Tu, X., Rhee, Y., Condon, K. W., Bivi, N., Allen, M. R., Dwyer, D., Stolina, M., Turner, C. H., Robling, A. G., Plotkin, L. I., et al. (2011) · Bone · doi:10.1016/j.bone.2011.10.025 · Cited by 475
Li, H., Xie, H., Liu, W., Hu, R., Huang, B., Tan, Y., Liao, E.-Y., Xu, K., Sheng, Z., Zhou, H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39832 · Cited by 464
van Amerongen, R., Bowman, A. N., & Nusse, R. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.023 · Cited by 454
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
Loots, G. G., Kneissel, M., Keller, H., Baptist, M., Chang, J., Collette, N. M., Ovcharenko, D., Plajzer-Frick, I., & Rubin, E. M. (2005) · Genome Research · doi:10.1101/gr.3437105 · Cited by 442
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Lobera, M., Madauss, K. P., Pohlhaus, D. T., Wright, Q. G., Trocha, M., Schmidt, D. R., Baloglu, E., Trump, R. P., Head, M. S., Hofmann, G. A., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1223 · Cited by 385
Genome-scale loss-of-function screening with a lentiviral RNAi library
Root, D. E., Hacohen, N., Hahn, W. C., Lander, E. S., & Sabatini, D. M. (2006) · Nature Methods · doi:10.1038/nmeth924 · Cited by 364
Self-citationNew sequence variants associated with bone mineral density
Styrkársdóttir, U., Halldórsson, B. V., Grétarsdóttir, S., Gudbjartsson, D. F., Walters, G. B., Ingvarsson, Þ., Jónsdóttir, Þ., Saemundsdottir, J., Snorradóttir, S., Nguyen, T. V., et al. (2008) · Nature Genetics · doi:10.1038/ng.284 · Cited by 361
Repression of Runx2 function by TGF‐β through recruitment of class II histone deacetylases by Smad3
Kang, J. S., Alliston, T. N., Delston, R. B., & Derynck, R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600729 · Cited by 354
Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation
Jeon, E.-J., Lee, K.-Y., Choi, N.-S., Lee, M., Kim, H.-N., Jin, Y.-H., Ryoo, H., Choi, J., Yoshida, M., Nishino, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512494200 · Cited by 343
Genetics of osteoporosis from genome-wide association studies: advances and challenges
Richards, J. B., Zheng, H., & Spector, T. D. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3228 · Cited by 312
Identification of differentially expressed genes between osteoblasts and osteocytes
Paić, F., Igwe, J. C., Nori, R., Kronenberg, M. S., Franceschetti, T., Harrington, P., Kuo, L., Shin, D., Rowe, D. W., Harris, S. E., et al. (2009) · Bone · doi:10.1016/j.bone.2009.06.010 · Cited by 271
Class IIa histone deacetylases: regulating the regulators
Martin, M., Kettmann, R., & Dequiedt, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210613 · Cited by 253
Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors
Leupin, O., Krämer, I., Collette, N. M., Loots, G. G., Natt, F., Kneissel, M., & Keller, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070804 · Cited by 248
Woo, S. M., Rosser, J., Dusevich, V., Kalajzic, I., & Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.465 · Cited by 243
Where Wnts Went: The Exploding Field of Lrp5 and Lrp6 Signaling in Bone
Williams, B. O., & Insogna, K. L. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081235 · Cited by 213
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling
Rhee, Y., Allen, M. R., Condon, K., Lezcano, V., Ronda, A. C., Galli, C., Olivos, N., Passeri, G., O'Brien, C. A., Bivi, N., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.304 · Cited by 208
Naya, F. J., Wu, C., Richardson, J. A., Overbeek, P. A., & Olson, E. N. (1999) · Development · doi:10.1242/dev.126.10.2045 · Cited by 172
Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling
Fulzele, K. S., Krause, D. S., Panaroni, C., Saini, V., Barry, K. J., Liu, X., Lotinun, S., Baron, R., Bonewald, L. F., Feng, J. Q., et al. (2012) · Blood · doi:10.1182/blood-2012-06-437160 · Cited by 152
Self-citationSclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading
Spatz, J., Ellman, R., Cloutier, A., Louis, L. D., Vliet, M. V., Suva, L. J., Dwyer, D., Stolina, M., Ke, H. Z., & Bouxsein, M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1807 · Cited by 150
Self-citationRegulatory signal transduction pathways for class IIa histone deacetylases
Parra, M., & Verdin, E. M. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.04.004 · Cited by 147
Kozhemyakina, E. A., Cohen, T., Yao, T., & Lassar, A. B. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00415-09 · Cited by 141
Targeted deletion of Sost distal enhancer increases bone formation and bone mass
Collette, N. M., Genetos, D. C., Economides, A. N., Xie, L., Shahnazari, M., Yao, W., Lane, N. E., Harland, R. M., & Loots, G. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207188109 · Cited by 139
Kinetic Responses of β-Catenin Specify the Sites of Wnt Control
Hernandez, A., Klein, A. M., & Kirschner, M. W. (2012) · Science · doi:10.1126/science.1228734 · Cited by 134
Galea, G. L., Meakin, L. B., Sugiyama, T., Zebda, N., Sunters, A., Taipaleenmäki, H., Stein, G. S., van Wijnen, A. J., Lanyon, L. E., & Price, J. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.405456 · Cited by 126
Wu, J. Y., Aarnisalo, P., Bastepe, M., Sinha, P. S., Fulzele, K. S., Selig, M. K., Chen, M., Poulton, I. J., Purton, L. E., Sims, N. A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46406 · Cited by 106
Self-citationNuclear Import of Histone Deacetylase 5 by Requisite Nuclear Localization Signal Phosphorylation
Greco, T. M., Yu, F., Guise, A. J., & Cristea, I. M. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004317 · Cited by 90
Mef2c deletion in osteocytes results in increased bone mass
Krämer, I., Baertschi, S., Halleux, C. M., Keller, H., & Kneissel, M. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1492 · Cited by 87
Shimizu, E., Selvamurugan, N., Westendorf, J., Olson, E., & Partridge, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094862 · Cited by 86
Kim, J. H., Kim, K., Youn, B. U., Jin, H. M., Kim, J.-Y., Moon, J. B., Ko, A., Seo, S., Lee, K.-Y., & Kim, N. (2011) · Biochemical Journal · doi:10.1042/bj20110062 · Cited by 80
HDAC4 integrates PTH and sympathetic signaling in osteoblasts
Obri, A., Makinistoglu, M. P., Zhang, H., & Karsenty, G. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201403138 · Cited by 60
Studying Osteocyte Function Using the Cell Lines MLO-Y4 and MLO-A5
Rosser, J. L., & Bonewald, L. F. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-415-5_6 · Cited by 54
Class I and IIa Histone Deacetylases Have Opposite Effects on Sclerostin Gene Regulation
Baertschi, S., Baur, N., Lueders-Lefevre, V., Voshol, J., & Keller, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.564997 · Cited by 46
Shimizu, E., Nakatani, T., He, Z., & Partridge, N. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.550699 · Cited by 45
Keratocan is Expressed by Osteoblasts and Can Modulate Osteogenic Differentiation
Igwe, J. C., Gao, Q., Kizivat, T., Kao, W. W. ‐., & Kalajzić, I. (2011) · Connective Tissue Research · doi:10.3109/03008207.2010.546536 · Cited by 40
Yu, L., van der Valk, M., Cao, J., Han, C.-Y. E., Juan, T., Bass, M., Deshpande, C., Damore, M. A., Stanton, R., & Babij, P. (2011) · Bone · doi:10.1016/j.bone.2011.08.016 · Cited by 33
Self-citationHasegawa, T., Amizuka, N., Yamada, T., Liu, Z., Miyamoto, Y., Yamamoto, T., Sasaki, M., Hongo, H., Suzuki, R., de Freitas, P. H. L., et al. (2013) · Biomedical Research · doi:10.2220/biomedres.34.153 · Cited by 24
Lentivirus Delivery of shRNA Constructs into Osteoblasts
Wein, M. N., Jones, D. C., & Glimcher, L. H. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-104-8_11 · Cited by 6
Self-citation
Flagged first, then by citations
1 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mechanical regulation of bone remodeling
Wang, L., You, X., Zhang, L., Zhang, C., & Zou, W. (2022) · Bone Research · doi:10.1038/s41413-022-00190-4 · Cited by 641
Zhu, S., Chen, W., Masson, A., & Li, Y. (2024) · Cell Discovery · doi:10.1038/s41421-024-00689-6 · Cited by 538
Bone remodeling: an operational process ensuring survival and bone mechanical competence
Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482
The Regulation of Bone Metabolism and Disorders by Wnt Signaling
Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., Kayama, T., Saito, M., & Marumo, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225525 · Cited by 360
The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro
Spatz, J., Wein, M. N., Gooi, J. H., Qu, Y., Garr, J., Liu, X. S., Barry, K. J., Uda, Y., Lai, F., Dedic, C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628313 · Cited by 304
Self-citation
Metadata
- Authors
- Wein, M. N., Spatz, J., Nishimori, S., Doench, J., Root, D., Babij, P., Nagano, K., Baron, R., Brooks, D., Bouxsein, M., Pajevic, P. D., & Kronenberg, H. M.
- Affiliations
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Amgen (United States) (US)
- Harvard University (US)
- Corresponding author
- Kronenberg, Henry M
- ORCID
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-01
- Volume
- 30
- Issue
- 3
- Pages
- 400-411
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- PMC
- PMC4342334
- OpenAlex
- W2151454340
- Cited by
- 158
- References
- 64
- Citations by year
- 2026: 11 · 2025: 6 · 2024: 7 · 2023: 10 · 2022: 12 · 2021: 17 · 2020: 18 · 2019: 14 · 2018: 10 · 2017: 25 · 2016: 15 · 2015: 11 · 2014: 2
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK11794, P01DK011794, F32DK100215, T32DK007028)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (UH3AR059655)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- HDAC5, sclerostin, MEF2C, osteocytes, histone deacetylase, transcriptional regulation, enhancers, Wnt signaling, bone formation, osteoporosis, H3K27 acetylation, NCoR, HDAC3, chromatin binding
- MeSH terms
- Animals, Glycoproteins, Histone Deacetylases, Osteocytes, Mice, Knockout, Intercellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice, MEF2 Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
